Multaq — CareFirst (Caremark)
To reduce the risk of hospitalization for atrial fibrillation in patients in sinus rhythm with a history of paroxysmal or persistent (non-permanent) atrial fibrillation
Initial criteria
- The requested drug is being prescribed to reduce the risk of hospitalization for atrial fibrillation (AF)
- Patient has a history of paroxysmal or persistent (non-permanent) atrial fibrillation
- Patient is in sinus rhythm
Approval duration
12 months